Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF266 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | EFNA4 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
mRNA | CDKN1A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | HAUS1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | IRAK4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
mRNA | ZBTB12 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | FBLN7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | GNGT1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | TMEM247 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | ZNF443 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |